TGTX
TG Therapeutics Inc
57.40$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +0.0% | +0.0% | -0.3% | +0.0% | +0.0% | +4,300.7% | -58.4% | +8,290.0% | +40.8% | +87.3% | |
| – | +13.3% | +24.9% | +50.2% | -99.9% | +220.5% | +32.6% | +111.2% | -66.5% | +5,232.5% | +172.4% | +161.7% | |
| – | +0.0% | +0.0% | +0.0% | -58.0% | +137.5% | +0.0% | +3,780.9% | -57.3% | +8,611.5% | +32.3% | +77.5% | |
| – | +38.6% | +53.0% | +45.7% | +58.7% | +0.3% | +7.6% | +34.2% | -43.7% | -39.2% | +23.8% | +69.9% | |
| – | -1.0% | -19.2% | +74.0% | -31.0% | -0.9% | +617.7% | +18.8% | -25.5% | +28.5% | +25.7% | +50.4% | |
| – | +13.3% | +24.9% | +50.2% | +46.9% | -3.1% | +61.8% | +28.1% | -37.0% | -9.9% | +25.0% | +57.8% | |
| – | – | – | – | – | – | – | – | – | – | +103.2% | +194.1% | |
| – | +4.5% | -100.0% | – | +52.2% | +204.9% | +19.7% | -10.9% | +80.8% | +23.8% | +90.5% | +11.2% | |
| – | – | – | – | – | – | – | – | – | – | +95.9% | +319.6% | |
| – | -484.4% | – | – | – | – | +0.3% | +14.7% | -26.2% | -92.9% | +466.9% | -15,468.1% | |
| – | – | – | – | – | – | – | – | – | – | +84.5% | +1,812.4% | |
| – | – | – | – | – | – | – | – | – | – | +91.2% | +169.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.